These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9067070)

  • 1. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.
    Ghaemi SN; Sachs GS; Baldassano CF; Truman CJ
    Can J Psychiatry; 1997 Mar; 42(2):196-9. PubMed ID: 9067070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
    Yatham LN; Fallu A; Binder CE
    Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone: a review of its use in the treatment of bipolar mania.
    Fenton C; Scott LJ
    CNS Drugs; 2005; 19(5):429-44. PubMed ID: 15907153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term risperidone treatment in bipolar disorder: 6-month follow up.
    Ghaemi SN; Sachs GS
    Int Clin Psychopharmacol; 1997 Nov; 12(6):333-8. PubMed ID: 9547135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.
    Pae CU; Nassir Ghaemi S; Patkar A; Chae JH; Bahk WM; Jun TY; Masand P
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1322-5. PubMed ID: 16631294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
    Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
    J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone in the treatment of mania.
    Tohen M; Zarate CA; Centorrino F; Hegarty JI; Froeschl M; Zarate SB
    J Clin Psychiatry; 1996 Jun; 57(6):249-53. PubMed ID: 8666562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
    J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of risperidone in bipolar II: an open 6-month study.
    Vieta E; Gastó C; Colom F; Reinares M; Martínez-Arán A; Benabarre A; Akiskal HS
    J Affect Disord; 2001 Dec; 67(1-3):213-9. PubMed ID: 11869771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
    Bahk WM; Shin YC; Woo JM; Yoon BH; Lee JS; Jon DI; Chung SK; Choi SK; Paik IH; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination pharmacotherapy in children and adolescents with bipolar disorder.
    Kowatch RA; Sethuraman G; Hume JH; Kromelis M; Weinberg WA
    Biol Psychiatry; 2003 Jun; 53(11):978-84. PubMed ID: 12788243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and continuation risperidone monotherapy in mania.
    Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
    Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.